Results 11 to 20 of about 2,534,766 (303)

Risk Factors for Conversion of Laparoscopic Colorectal Surgery to Open Surgery: Does Conversion Worsen Outcome? [PDF]

World Journal of Surgery, 2015
AbstractIntroductionThe utilization of laparoscopy in colorectal surgery is increasing. However, conversion to open surgery remains relatively high.ObjectiveWe evaluated (1) conversion rates in laparoscopic colorectal surgery; (2) the outcomes of converted cases compared with successful laparoscopic and open colorectal operations; (3) predictive risk ...
Masoomi, H, Moghadamyeghaneh, Z, Mills, S, Carmichael, JC, Pigazzi, A, Stamos, MJ   +5 more
openaire   +7 more sources

Fontan conversion with arrhythmia surgery☆ [PDF]

European Journal of Cardio-Thoracic Surgery, 2005
Hemodynamic abnormalities and refractory atrial arrhythmias in patients late after the Fontan operation result in significant morbidity and mortality. We reviewed our experience with Fontan conversion and concomitant arrhythmia surgery.Between January 1996 and February 2004, 16 patients underwent Fontan conversion and arrhythmia surgery.
Woong-Han, Kim, Hong Gook, Lim, Jeong Ryul, Lee, Joon Ryang, Rho, Eun Jung, Bae, Chung Il, Noh, Yong Soo, Yoon, Yong Jin, Kim   +7 more
openaire   +3 more sources

Outcomes of Conversion of Laparoscopic Colorectal Surgery to Open Surgery [PDF]

JSLS : Journal of the Society of Laparoendoscopic Surgeons, 2014
There is limited data regarding the outcomes of patients who undergo conversion to open surgery during a laparoscopic operation in colorectal resection. We sought to identify the outcomes of such patients.The NIS (National Inpatient Sample) database was used to identify patients who had conversion from laparoscopic to open colorectal surgery during the
Moghadamyeghaneh, Zhobin, Masoomi, Hossein, Mills, Steven D, Carmichael, Joseph C, Pigazzi, Alessio, Nguyen, Ninh T, Stamos, Michael J   +6 more
openaire   +6 more sources

Conversion Surgery after Chemotherapy in a Stage IV BRAF V600E‐Mutated Laterally Spreading Tumor With Neuroendocrine Component [PDF]

DEN Open
We report a rare case of a BRAF V600E‐mutated laterally spreading tumor, granular type (LST‐G), with a neuroendocrine carcinoma (NEC) component in a patient with stage IV colorectal cancer.
Reona Kawamura, Naoya Toyoshima, Masau Sekiguchi, Hiroyuki Takamaru, Masayoshi Yamada, Nozomu Kobayashi, Hidekazu Hirano, Yasuyuki Takamizawa, Taiki Hashimoto, Yutaka Saito   +9 more
doaj   +2 more sources

Durvalumab induced immune-related agranulocytosis after conversion surgery in a patient with intrahepatic cholangiocarcinoma: a case report [PDF]

Frontiers in Immunology
We report a rare hematological immune-related adverse event (irAE) induced by durvalumab, an immune checkpoint inhibitor, after conversion surgery in a patient with intrahepatic cholangiocarcinoma (ICC).
Yoshihito Kitamura, Seiichi Shimizu, Shintaro Kuroda, Naruhiko Honmyo, Ryosuke Nakano, Hiroshi Sakai, Hiroyuki Tahara, Masahiro Ohira, Kentaro Ide, Tsuyoshi Kobayashi, Tatsuo Ichinohe, Hideki Ohdan   +11 more
doaj   +2 more sources

A Mucosal Change like Hypertrophic Gastritis Following Zolbetuximab-Based Therapy in a Conversion Surgery Case of Advanced Gastric Cancer [PDF]

Reports
Background and Clinical Significance: Zolbetuximab, a claudin 18.2-targeted monoclonal antibody, has demonstrated efficacy in advanced gastric cancer. Hypoalbuminemia has emerged as a notable adverse effect, but its underlying mechanism remains unclear ...
Soshi Oyama, Shuhei Suzuki, Takanobu Kabasawa, Takumi Kanauchi, Shotaro Akiba   +4 more
doaj   +2 more sources

Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma

Annals of Gastroenterological Surgery, 2020
Aim of this review is to propose an acceptable surgical indication for conversion surgery in patients with initially unresectable (UR) pancreatic ductal adenocarcinoma (PDAC) by considering desirable outcomes, including resectability, overall survival ...
Sohei Satoi, Tomohisa Yamamoto, So Yamaki, Tatsuma Sakaguchi, Mitsugu Sekimoto   +4 more
doaj   +2 more sources

Unexpectedly High Incidence of Immune‐Related Adverse Events in Gastric Cancer Patients Who Received Conversion Surgery After Nivolumab‐Including Chemotherapy [PDF]

Annals of Gastroenterological Surgery
Background Nivolumab‐including chemotherapy (nivo‐CTX) for stage IV gastric cancer (GC) may increase the chance of conversion surgery but risk of immune‐related adverse events (irAEs) during perioperative period remains unclear. Methods We examined irAEs
Masashi Nishino, Takaki Yoshikawa, Hirokazu Shoji, Yuki Takenaka, Maho Takuwa, Yurina Fujisaki, Rei Ogawa, Takeyuki Wada, Tsutomu Hayashi, Yukinori Yamagata, Nobuyoshi Hiraoka, Yasuyuki Seto   +11 more
doaj   +2 more sources

Factors Affecting Conversion of Laparoscopic Cholecystectomy to Open Surgery

Archives of Surgery, 1996
To identify the risk factors predictive of conversion of laparoscopic cholecystectomy to open surgery.Demographic, ultrasonographic, and operative data of patients who underwent laparoscopic cholecystectomy were analyzed. Factors affecting conversion to open surgery were identified with statistical analysis.A tertiary referral center.Five hundred ...
Lai, ECS, Fan, ST, Chu, KM, Lo, CM, Liu, CL   +4 more
openaire   +4 more sources

Conversion Surgery for Stage IV Gastric Cancer [PDF]

Frontiers in Oncology, 2019
The prognosis of stage IV gastric cancer (GC) is poor, with palliative chemotherapy remaining the main therapeutic option. Studies increasingly indicate that patients with unresectable stage IV GC, who undergo gastrectomy with radical intention after ...
Fei Zhang, Xuanzhang Huang, Yongxi Song, Peng Gao, Cen Zhou, Zhexu Guo, Jinxin Shi, Zhonghua Wu, Zhenning Wang   +8 more
doaj   +3 more sources